Digitalis Ventures logo

Digitalis Ventures

North America, New York, United States, New York

Description

Digitalis is a venture capital firm that that invests in solutions to complex problems in human and animal health.

Investor Profile

Digitalis Ventures has made 77 investments, with 11 in the past 12 months and 14% as lead.

Stage Focus

  • Series A (42%)
  • Seed (25%)
  • Series B (22%)
  • Series C (5%)
  • Series Unknown (3%)
  • Convertible Note (1%)
  • Pre Seed (1%)
  • Series D (1%)

Country Focus

  • United States (88%)
  • United Kingdom (5%)
  • Australia (3%)
  • China (3%)
  • Canada (1%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Therapeutics
  • Life Science
  • Pharmaceutical
  • Software
  • Artificial Intelligence (Ai)
  • Health Diagnostics
  • Biopharma
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Digitalis Ventures frequently co-invest with?

Two Sigma Ventures
North America, New York, United States, New York
Co-Investments: 5
Blue Owl
North America, New York, United States, New York
Co-Investments: 4
CF
North America, New York, United States, New York
Co-Investments: 4
3×5 Partners
North America, Oregon, United States, Portland
Co-Investments: 4
KdT Ventures
North America, Texas, United States, Austin
Co-Investments: 11
Alexandria Venture Investments
North America, California, United States, Pasadena
Co-Investments: 6
RiverVest
North America, Missouri, United States, St Louis
Co-Investments: 7
F-Prime Capital
North America, Massachusetts, United States, Cambridge
Co-Investments: 4
Roche Venture Fund
Europe, Basel-Stadt, Switzerland, Basel
Co-Investments: 5
Innovation Endeavors
North America, California, United States, Palo Alto
Co-Investments: 4

Which angels does Digitalis Ventures often collaborate with?

ZW
North America, New York, United States, New York
Shared Deals: 1
EL
North America, Florida, United States, Miami Beach
Shared Deals: 3
NB
North America, New York, United States, New York
Shared Deals: 1
RB
North America, California, United States, San Francisco
Shared Deals: 1
NT
North America, New York, United States, New York
Shared Deals: 1
NR
North America, California, United States
Shared Deals: 1
Matthew Winkler
North America, Texas, United States, Austin
Shared Deals: 1
JO
North America, Florida, United States, Miami
Shared Deals: 1
JZ
North America, California, United States, Campbell
Shared Deals: 1
JB
North America, North Dakota, United States, Fargo
Shared Deals: 1

What are some of recent deals done by Digitalis Ventures?

Galatea Bio

Miami Lakes, Florida, United States

Galatea Bio’s mission is to drive groundbreaking discoveries in healthcare by pairing genetic diversity with cutting-edge data analytics.

Artificial Intelligence (AI)Big DataBiopharmaBiotechnologyHealth CareLife ScienceMachine LearningMedicalPharmaceutical
Series UnknownMar 27, 2025
Amount Raised: $8,000,000
Aviceda Therapeutics

Cambridge, Massachusetts, United States

Aviceda Therapeutics is a late-stage pre-clinical biotech company developing drugs for treating glyco-immune diseases.

BiotechnologyHealth CareLife SciencePharmaceuticalTherapeutics
Series CJan 7, 2025
Amount Raised: $207,500,000
Nuvig Therapeutics

Redwood City, California, United States

Nuvig Therapeutics is a biotechnology company developing therapies to induce natural mechanisms to restore immune homeostasis.

BiotechnologyHealth CareTherapeutics
Series BDec 5, 2024
Amount Raised: $161,000,000
Alpha9 Theranostics

Vancouver, British Columbia, Canada

Alpha9 Theranostics is a biopharma company that focuses on radiotherapeutics for the treatment of solid and hematologic malignancies.

BiotechnologyMedicalProduct Research
Series COct 23, 2024
Amount Raised: $175,000,000
Terray Therapeutics

Monrovia, California, United States

Terray Therapeutics is a biotechnology company that transforms small molecule drug discovery.

Artificial Intelligence (AI)BiopharmaBiotechnologyLife ScienceMedical
Series BOct 17, 2024
Amount Raised: $120,000,000
Reema Health

Minneapolis, Minnesota, United States

Reema Health is a technology startup transforming how people navigate the gaps between health care and social care.

Health CareSocialSoftware
Series AOct 10, 2024
Amount Raised: $7,500,000
Judo Bio

Cambridge, Massachusetts, United States

Judo Bio is a biotechnology company that develops precision therapeutics targeting specific cell populations to address genetic diseases.

BiotechnologyLife ScienceMedicalTherapeutics
Series AOct 7, 2024
Amount Raised: $75,000,000
GRO Biosciences

Boston, Massachusetts, United States

GRO Biosciences is a biotechnology company that develops a protein therapeutics technology to improve treatments across multiple diseases.

BiotechnologyHealth DiagnosticsMedicalPharmaceuticalTherapeutics
Series BJul 19, 2024
Amount Raised: $60,300,000
Cardurion Pharmaceuticals

Boston, Massachusetts, United States

Cardurion is a cardiovascular biotechnology company developing therapeutics for the treatment of heart failure and cardiovascular diseases.

BiotechnologyHealth CareMedicalPharmaceutical
Series BJul 16, 2024
Amount Raised: $260,000,000
Expressable

Austin, Texas, United States

Expressable is an online speech therapy platform designed for individuals with communication disorders.

E-LearningHealth CareTherapeuticsTraining
Series BMay 20, 2024
Amount Raised: $26,000,000